Claims
- 1. A compound represented by the formula: ##STR12## where R is a lower alkyl group having 1 to 4 carbon atoms; R.sup.1 is -SOR.sup.2, -SO.sub.2 R.sup.2, -SCN, -SR.sup.5, -OR.sup.5, or M' (CH.sub.2).sub.n MR.sup.7 where M and M'are independently O, S, ##STR13## R.sup.7 is lower alkyl having 1 to 4 carbon atoms, phenyl or naphthyl, and n is 1-4; R.sup.2 is lower alkyl having from 1 to 6 carbon atoms, cycloalkyl having 3 to 7 carbon atoms, lower alkenyl or lower alkynyl having 3 to 6 carbon atoms, benzyl, phenethyl, phenyl or naphthyl; and R.sup.5 is lower alkenyl, lower alkynyl, or benzyl or phenethyl; the R.sup.1 substitution being at the 5(6)-position; or a pharmaceutically acceptable salt thereof.
- 2. A compound represented by the formula: ##STR14## where R is a lower alkyl group having 1 to 4 carbon atoms; R.sup.1 is -SOR.sup.2 or -SO.sub.2 R.sup.2, R.sup.2 is lower alkyl having from 1 to 6 carbon atoms or cycloalkyl having 3 to 7 carbon atoms; said lower alkyl group of said R.sup.2 substituent being optionally substituted with one or more alkoxy having 1 to 6 carbon atoms, phenyl, naphthyl, thiocyanato, benzoyl, naphthoyl hydroxy, cycloalkyl having 3 to 7 carbon atoms, halo, cyano, or nitro radicals; the R.sup.1 substitution being at the 5(6)-position; or a pharmaceutically acceptable salt thereof.
- 3. The compound of claim 2 wherein R.sup.2 is lower alkyl.
- 4. The compound of claim 2 wherein R is methyl.
- 5. The compound of claim 2 wherein said compound is 5(6)-methylsulfinyl-2-carbomethoxyaminobenzimidazole.
- 6. The compound of claim 2 wherein said compound is 5(6)-ethylsulfinyl-2-carbomethoxyaminobenzimidazole.
- 7. The compound of claim 2 wherein said compound is 5(6)-n-propylsulfinyl-2-carbomethoxyaminobenzimidazole.
- 8. The compound of claim 2 wherein said compound is 5(6)-i-propylsulfinyl-2-carbomethoxyaminobenzimidazole.
- 9. The compound of claim 2 wherein said compound is 5(6)-n-butylsulfinyl-2-carbomethoxyaminobenzimidazole.
- 10. The compound of claim 2 wherein said compound is 5(6)-trifluoromethylmethylsulfinyl-2-carbomethoxyaminobenzimidazole.
- 11. A compound represented by the formula: ##STR15## where R is lower alkyl group having 1 to 4 carbon atoms; R.sup.1 is -SCN; the R.sup.1 substitution being at the 5(6)-position; or a pharmaceutically acceptable salt thereof.
- 12. A compound represented by the formula: ##STR16## where R is a lower alkyl group having 1 to 4 carbon atoms; R.sup.1 is M'(CH.sub.2).sub.n MR.sup.7 where M and M' are independently O, S, ##STR17## R.sup.7 is lower alkyl having 1 to 4 carbon atoms, phenyl or naphthyl, and n is 1-4; the R.sup.1 substitution being at the 5(6)-position; or a pharmaceutically acceptable salt thereof.
- 13. The compound of claim 12 wherein said compound is 5(6)-methylsulfinylethylthio-2-carbomethoxyaminobenzimidazole.
- 14. The compound of claim 12 wherein said compound is 5(6)-methylsulfinylmethylthio-2-carbomethoxyaminobenzimidazole.
- 15. The compound of claim 12 wherein said compound is 5(6)-phenylsulfinylmethylthio-2-carbomethoxyaminobenzimidazole.
REFERENCE TO PARENT APPLICATIONS
This application is a division of application Ser. No. 417,963, filed Nov. 21, 1973 now U.S. Pat. No. 3,929,827, which, in turn, is a continuation-in-part application of application Ser. No. 319,299, filed Dec. 29, 1972, now abandoned
US Referenced Citations (3)
Number |
Name |
Date |
Kind |
3682952 |
Actor et al. |
Aug 1972 |
|
3929821 |
Beard et al. |
Dec 1975 |
|
3929824 |
Beard et al. |
Dec 1975 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
809,234 |
Jun 1974 |
BE |
Divisions (1)
|
Number |
Date |
Country |
Parent |
417963 |
Nov 1973 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
319299 |
Dec 1972 |
|